Five-year Local Control in a Phase II Study of Hypofractionated Intensity Modulated Radiation Therapy With an Incorporated Boost for Early Stage Breast Cancer-Reference-Cited by-同舟云学术

Five-year Local Control in a Phase II Study of Hypofractionated Intensity Modulated Radiation Therapy With an Incorporated Boost for Early Stage Breast Cancer

Published:2012-11 Issue:4 Volume:84 Page:888-893
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Freedman Gary M.,Anderson Penny R.,Bleicher Richard J.,Litwin Samuel,Li Tianyu,Swaby Ramona F.,Ma Chang-Ming Charlie,Li Jinsheng,Sigurdson Elin R.,Watkins-Bruner Deborah,Morrow Monica,Goldstein Lori J.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference30 articles.

1. National Comprehensive Cancer Network. NCCN practice guidelines for breast cancer. Version 1 2012. Available at: http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf. Accessed Jan. 1, 2012.

2. Treatment of early-stage breast cancer;JAMA,1991

3. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials;Lancet,2005

4. Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma;Lazovich;Cancer,1999

5. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma;Morrow;J Clin Oncol,2001

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials;The Breast;2022-08

2. Long-term oncological outcomes of hypofractionated versus conventional fractionated whole breast irradiation with simultaneous integrated boost in early-stage breast cancer;Radiation Oncology Journal;2022-06-30

3. Long-term results of hypofractionation with concomitant boost in patients with early breast cancer: A prospective study;PLOS ONE;2021-10-07

4. Acute and intermediate toxicity of 3-week radiotherapy with simultaneous integrated boost using TomoDirect: prospective series of 287 early breast cancer patients;Clinical and Translational Oncology;2021-02-03

Intensity-Modulated Radiotherapy with Concomitant Boost After Breast Conserving Surgery: A Phase I–II Trial

;Breast Cancer: Targets and Therapy;2020-11